Becerde, Merygrace O.
HRN: 12-19-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/03/2024
07/09/2024
IV
300mg
Q6
Hack Wound Secondary To Hacking(bolo)
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose
Overall appropriateness: No Wrong Dose